DK1608309T3 - 10,10-Dialkylprostanoidsyrederivater som midler til reduktion af det intraokulare tryk - Google Patents

10,10-Dialkylprostanoidsyrederivater som midler til reduktion af det intraokulare tryk

Info

Publication number
DK1608309T3
DK1608309T3 DK04709028.7T DK04709028T DK1608309T3 DK 1608309 T3 DK1608309 T3 DK 1608309T3 DK 04709028 T DK04709028 T DK 04709028T DK 1608309 T3 DK1608309 T3 DK 1608309T3
Authority
DK
Denmark
Prior art keywords
agents
acid derivatives
intraocular pressure
reducing intraocular
prostanoic acid
Prior art date
Application number
DK04709028.7T
Other languages
English (en)
Inventor
Yariv Donde
Jeremiah H Nguyen
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Priority claimed from PCT/US2004/003433 external-priority patent/WO2004071428A2/en
Application granted granted Critical
Publication of DK1608309T3 publication Critical patent/DK1608309T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
DK04709028.7T 2003-02-11 2004-02-06 10,10-Dialkylprostanoidsyrederivater som midler til reduktion af det intraokulare tryk DK1608309T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/365,369 US6875787B2 (en) 2003-02-11 2003-02-11 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
US10/772,720 US20040235958A1 (en) 2003-02-11 2004-02-04 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
PCT/US2004/003433 WO2004071428A2 (en) 2003-02-11 2004-02-06 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure

Publications (1)

Publication Number Publication Date
DK1608309T3 true DK1608309T3 (da) 2012-09-03

Family

ID=32824631

Family Applications (2)

Application Number Title Priority Date Filing Date
DK10178294.4T DK2263674T3 (da) 2003-02-11 2004-02-06 10,10-Dialkyl-prostansyrederivater som midler til sænkning af intraokulært tryk
DK04709028.7T DK1608309T3 (da) 2003-02-11 2004-02-06 10,10-Dialkylprostanoidsyrederivater som midler til reduktion af det intraokulare tryk

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK10178294.4T DK2263674T3 (da) 2003-02-11 2004-02-06 10,10-Dialkyl-prostansyrederivater som midler til sænkning af intraokulært tryk

Country Status (13)

Country Link
US (2) US6875787B2 (da)
EP (2) EP2263674B1 (da)
CN (3) CN102050811A (da)
AR (1) AR043138A1 (da)
CY (1) CY1113138T1 (da)
DK (2) DK2263674T3 (da)
ES (2) ES2391393T3 (da)
HK (1) HK1086191A1 (da)
IL (1) IL170052A (da)
PT (1) PT1608309E (da)
SI (1) SI1608309T1 (da)
TW (1) TWI329631B (da)
ZA (1) ZA200505728B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7855226B2 (en) 2003-02-11 2010-12-21 Allergan, Inc. Treatment of inflammatory bowel disease
US7169807B2 (en) * 2004-04-09 2007-01-30 Allergan, Inc. 10-Hydroxy-11-dihydroprostaglandin analogs as selective EP4 agonists
EP1805139A2 (en) * 2004-10-26 2007-07-11 Allergan, Inc. Therapeutic and delivery methods of prostaglandin ep4 agonists
US7101906B2 (en) * 2004-11-16 2006-09-05 Allergan, Inc. 2,3,4-substituted cyclopentanones as therapeutic agents
TWI386208B (zh) * 2005-04-18 2013-02-21 Allergan Inc 治療性的經取代環戊酮
US7893107B2 (en) * 2005-11-30 2011-02-22 Allergan, Inc. Therapeutic methods using prostaglandin EP4 agonist components
US20070232660A1 (en) * 2006-04-04 2007-10-04 Allergan, Inc. Therapeutic and delivery methods of prostaglandin ep4 agonists
US9308070B2 (en) 2008-12-15 2016-04-12 Allergan, Inc. Pliable silk medical device
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
ES2414879T4 (es) 2009-04-20 2013-10-30 Allergan, Inc. Hidrogeles de fibroína de seda y usos de éstos
US20110052695A1 (en) * 2009-04-20 2011-03-03 Allergan, Inc. Drug delivery platforms comprising silk fibroin hydrogels and uses thereof
US20110111031A1 (en) * 2009-04-20 2011-05-12 Guang-Liang Jiang Drug Delivery Platforms Comprising Silk Fibroin Hydrogels and Uses Thereof
SG187653A1 (en) * 2010-07-30 2013-03-28 Allergan Inc Compounds and methods for skin repair
BR112013003600A2 (pt) * 2010-08-17 2016-08-16 Allergan Inc agonistas ep2 ou ep4 para o tratamento de névoa da córnea
US8697056B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US8741281B2 (en) * 2010-08-19 2014-06-03 Allergan, Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) * 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US20120142684A1 (en) * 2010-12-02 2012-06-07 Allergan, Inc. Compounds and methods for skin repair
CA2827615A1 (en) 2011-02-17 2012-08-23 Dennis E. Van Epps Compositions and improved soft tissue replacement methods
EP2678022A2 (en) 2011-02-23 2014-01-01 Allergan, Inc. Compositions and improved soft tissue replacement methods
US20120259413A1 (en) 2011-04-07 2012-10-11 Allergan, Inc. Devices, compositions and methods utilizing ep4 and ep2 receptor agonists for preventing, reducing or treating capsular contracture
WO2013123270A1 (en) 2012-02-16 2013-08-22 Allergan, Inc. Compositions and improved soft tissue replacement methods
EP2814526B1 (en) 2012-02-16 2016-11-02 Allergan, Inc. Compositions and improved soft tissue replacement methods
WO2013123272A1 (en) 2012-02-16 2013-08-22 Allergan, Inc. Compositions and improved soft tissue replacement methods
WO2013123275A1 (en) 2012-02-16 2013-08-22 Allergan, Inc. Compositions and improved soft tissue replacement methods
CA2941648C (en) 2014-03-07 2022-08-16 Dynaenergetics Gmbh & Co. Kg Device and method for positioning a detonator within a perforating gun assembly

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117014A (en) * 1976-01-09 1978-09-26 Abbott Laboratories Prostaglandin derivatives
JPS59101458A (ja) * 1982-12-01 1984-06-12 Nippon Iyakuhin Kogyo Kk 新規なチアプロスタグランジン誘導体及びその製法
JPS632972A (ja) * 1986-06-20 1988-01-07 Nippon Iyakuhin Kogyo Kk 新規プロスタグランジンｅ↓１誘導体及びその製法
US6187813B1 (en) * 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5028624A (en) 1989-07-27 1991-07-02 Allergan, Inc. Intraocular pressure reducing 9,15-diacyl prostaglandins
US4994274A (en) * 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
US5034413A (en) * 1989-07-27 1991-07-23 Allergan, Inc. Intraocular pressure reducing 9,11-diacyl prostaglandins
AU635294B2 (en) * 1989-07-27 1993-03-18 Allergan, Inc. Intraocular pressure reducing 9,11-diacyl prostaglandins
CA2021316C (en) * 1989-07-27 2000-10-24 Ming Fai Chan Intraocular pressure reducing 11-acyl prostaglandins
CA2020254A1 (en) * 1989-07-27 1991-01-28 Ming F. Chan Intraocular pressure reducing 9, 15-diacyl prostaglandins
US6034413A (en) * 1997-02-27 2000-03-07 Texas Instruments Incorporated High speed biCMOS gate power for power MOSFETs incorporating improved injection immunity
DE10057158C1 (de) * 2000-11-16 2002-03-28 Asglawo Gmbh Stoffe Zum Daemme Lagerungsmatte für die Lagerung eines Abgaskatalysators
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure
WO2003040126A1 (en) * 2001-11-05 2003-05-15 Allergan, Inc. φ-CYCLOALKYL 17-HETEROARYL PROSTAGLANDIN E2 ANALOGS AS EP2-RECEPTOR AGONISTS
US7175476B2 (en) * 2005-01-11 2007-02-13 Daeun Electronics Co., Ltd. Crosstalk canceling pattern for high-speed communications and modular jack having the same

Also Published As

Publication number Publication date
ES2515217T3 (es) 2014-10-29
CN1758915A (zh) 2006-04-12
DK2263674T3 (da) 2014-10-27
EP2803358B1 (en) 2017-05-03
SI1608309T1 (sl) 2012-11-30
US20040157901A1 (en) 2004-08-12
CN102050812B (zh) 2015-02-18
HK1086191A1 (en) 2006-09-15
EP2263674B1 (en) 2014-07-23
ZA200505728B (en) 2006-04-26
US20040235958A1 (en) 2004-11-25
US6875787B2 (en) 2005-04-05
CY1113138T1 (el) 2016-04-13
ES2391393T3 (es) 2012-11-23
EP2263674A1 (en) 2010-12-22
TW200512184A (en) 2005-04-01
IL170052A (en) 2011-10-31
TWI329631B (en) 2010-09-01
EP2803358A1 (en) 2014-11-19
PT1608309E (pt) 2012-10-18
CN102050811A (zh) 2011-05-11
AR043138A1 (es) 2005-07-20
CN102050812A (zh) 2011-05-11

Similar Documents

Publication Publication Date Title
DK1608309T3 (da) 10,10-Dialkylprostanoidsyrederivater som midler til reduktion af det intraokulare tryk
NO20053715D0 (no) 10,10-dialkylprostanoinsyrederivater som midler for a senke intraokulaert trykk
DK1503984T3 (da) 8-azaprostaglandin-analoger som midler til sænkning af intraokulært tryk
NO20052884D0 (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
NO20050652L (no) Pyrrolidone derivater som maob inhibitorer
DK1638928T3 (da) N-alkynyl-2-(substituerede aryloxy)alkylthio-amidderivater som fungicider
NO20044654L (no) Piperidinoylpiperidiner som 5-HTIF-agonister
NO20052887D0 (no) Pyridazinonderivater som GSK-3Beta inhibitorer.
DK1414803T3 (da) Pyrazolylcarboxanilider som fungicider
NO20053340D0 (no) Substituerte dihydropyrano-indol-3,4-dion-derivater som inhibitorer for plasmigogenaktivator-1 (CPAI-1).
NO20041567L (no) 1,8-nafthyridinderivater som antidiabetiske midler
HRP20120323T1 (en) Diarylhydantoin compounds
DK1902037T3 (da) 2,4-diamino-pyrimidiner som auroainhibitorer
DK1592457T3 (da) Folat-vinblastin-konjugat som lægemiddel
DK1585749T3 (da) Diazepinoindol-derivater som kinaseinhibitorer
DK1549341T3 (da) Mod vævsfaktor rettede antistoffer som antikoagulanter
NO20052993D0 (no) 4,5-diaryltiazolderivater som CB-1 ligander.
DK1492785T3 (da) 2-hydroxy-3-heteroarylindol-derivater som GSK3-inhibitorer
NO20033618D0 (no) Ftalayinon-piperidino-derivater som PDE-4-inhibitorer
NO20054787L (no) Indenderivater som farmasotiske midler
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
NO20054169D0 (no) 3-(1-[3-(1,3-benzotiazol-6-yl) propylkarbamoyl]sykloalkyl]propansyrederivater som NEP-inhibitorer.
DK1755562T3 (da) Kontraceptivum, som indeholder folsyre
NO20043794L (no) Benzensulfonamidderivater som antipsykotiske midler
DK1575948T3 (da) Pyridodiaziner som plantefungicider